| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics, Molecular Targets, and Chemical Biology |
1 Cancer Institute, The Second Affiliated Hospital, 2 Department of Neurobiology, and 3 The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China; 4 Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio
Requests for reprints: Xun Hu, Cancer Institute, Zhejiang University, 88 Jiefang Road, Hangzhou, Zhejiang, 310009 China. Phone: 86-571-8778-3656; E-mail: huxun{at}zju.edu.cn.
Previous reports have shown that honokiol induces apoptosis in numerous cancer cell lines and showed preclinical efficacies against apoptosis-resistant B-cell chronic lymphocytic leukemia and multiple myeloma cells from relapse-refractory patients. Here, we show that honokiol can induce a cell death distinct from apoptosis in HL60, MCF-7, and HEK293 cell lines. The death was characterized by a rapid loss of integrity of plasma membrane without externalization of phosphatidyl serine. The broad caspase inhibitor z-VAD-fmk failed to prevent this cell death. Consistently, caspase activation and DNA laddering were not observed. The death was paralleled by a rapid loss of mitochondrial membrane potential, which was mechanistically associated with the mitochondrial permeability transition pore regulated by cyclophilin D (CypD) based on the following evidence: (a) cyclosporin A, an inhibitor of CypD (an essential component of the mitochondrial permeability transition pore), effectively prevented honokiol-induced cell death and loss of mitochondrial membrane potential; (b) inhibition of CypD by RNA interference blocked honokiol-induced cell death; (c) CypD up-regulated by honokiol was correlated with the death rates in HL60, but not in K562 cells, which underwent apoptosis after being exposed to honokiol. We further showed that honokiol induced a CypD-regulated death in primary human acute myelogenous leukemia cells, overcame Bcl-2 and Bcl-XL–mediated apoptotic resistance, and was effective against HL60 cells in a pilot in vivo study. To the best of our knowledge, this is the first report to document an induction of mitochondrial permeability transition pore–associated cell death by honokiol. [Cancer Res 2007;67(10):4894–903]
This article has been cited by other articles:
![]() |
T.-C. Kuo, J.-S. Yang, M.-W. Lin, S.-C. Hsu, J.-J. Lin, H.-J. Lin, T.-C. Hsia, C.-L. Liao, M.-D. Yang, M.-J. Fan, et al. Emodin Has Cytotoxic and Protective Effects in Rat C6 Glioma Cells: Roles of Mdr1a and Nuclear Factor {kappa}B in Cell Survival J. Pharmacol. Exp. Ther., September 1, 2009; 330(3): 736 - 744. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-K. Sy, S.-C. Yan, C.-N. Lok, R. Y.K. Man, and C.-M. Che Timosaponin A-III Induces Autophagy Preceding Mitochondria-Mediated Apoptosis in HeLa Cancer Cells Cancer Res., December 15, 2008; 68(24): 10229 - 10237. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Shimony, I. Avrahami, R. Gorodetsky, G. Elkin, K. Tzukert, L. Zangi, L. Levdansky, L. Krasny, and Y. S. Haviv A 3D rotary renal and mesenchymal stem cell culture model unveils cell death mechanisms induced by matrix deficiency and low shear stress Nephrol. Dial. Transplant., June 1, 2008; 23(6): 2071 - 2080. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |